Clinical Trials Logo

Anemia clinical trials

View clinical trials related to Anemia.

Filter by:

NCT ID: NCT03286465 Completed - Anemia Clinical Trials

Use of Pediatric Size Phlebotomy Tubes in Adult Critically Ill Patients to Reduce Red Blood Cell Transfusions

Start date: November 7, 2017
Phase: N/A
Study type: Interventional

This study will evaluate the hypothesis that the use of pediatric size phlebotomy tubes reduces red blood cell (RBC) transfusions in adult intensive care unit (ICU) patients compared with the use of adult size tubes.

NCT ID: NCT03284944 Completed - Blood Loss Anemia Clinical Trials

Small-Volume Tubes to Reduce Anemia and Transfusion (STRATUS)

Start date: November 1, 2017
Phase:
Study type: Observational

STRATUS will evaluate the use of small-volume ("soft-draw") blood collection tubes for laboratory testing in reducing anemia and transfusion in intensive care unit patients without significant adverse consequences. This is a simple, cost-neutral intervention that could improve the quality of patient care and reduce the harms of frequent laboratory testing.

NCT ID: NCT03279536 Completed - Clinical trials for Iron Deficiency Anemia

Lactoferrin Versus Total Dose Infusion (TDI) For Treating Iron Deficiency Anemia in Pregnancy: Role of Nursing

TDI
Start date: November 1, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

This study consisted of 60 cases. All the cases of pregnant women are 4 months to 8 months of pregnancy. The cases divided into 30 pregnant women's were given iron supplementation without health education and another 30 were given iron supplementation and health education for comparison between them. Comparative between hemoglobin levels before and after medication. Treatment of iron deficiency anemia with iron supplementation received for one month.

NCT ID: NCT03269292 Completed - Clinical trials for Autoimmune Hemolytic Anemia

Clinical Characteristics and Treatment Outcomes of Patients With Autoimmune Hemolytic Anemia

Start date: October 1, 2017
Phase:
Study type: Observational

Autoimmune hemolytic anemia is characterized by shortened red blood cell survival and a positive Coombs test. The responsible autoantibodies may be either warm reactive or cold reactive. The rate of hemolysis and the severity of the anemia may vary from mild to severe and life-threatening. Diagnosis is made in the laboratory by the findings of anemia, reticulocytosis, a positive Coombs test, and specific serologic tests. The prognosis is generally good but renal failure and death sometimes occur, especially in cases mediated by drugs.

NCT ID: NCT03251664 Completed - Anemia Clinical Trials

Food Groups Associated With Anaemia in Pregnant Women

Start date: October 1, 2015
Phase: N/A
Study type: Observational [Patient Registry]

This study investigates the association between locally consumed food items with anemia among pregnant women, in Addis Ababa city, Ethiopia.

NCT ID: NCT03247816 Completed - Clinical trials for Inflammatory Bowel Diseases

Feraccru® Real World Effectiveness Study in Hospital Practice ( FRESH )

FRESH
Start date: August 14, 2017
Phase:
Study type: Observational

The aim of the study is to understand the early experiences of Feraccru® in patients with inflammatory bowel disease (IBD) and iron deficiency anaemia (IDA) in the UK, including treatment effectiveness, patterns of use and tolerability.

NCT ID: NCT03241381 Completed - Clinical trials for Melasma, Periodontitis, Vitamin D Abnormalities, Anaemia

Prevalence of Serum-Vitamin D Abnormalities, Periodontitis and Anaemia in Patients With Melasma

Start date: October 2016
Phase: N/A
Study type: Observational

Melasma is a commonly pigmention characterized by melanotic patches on the face. literature searched revealed that periodontitis and vitamin D deficiency have occurred along with anemia. Actinic associated factors may be indirectly related to vitamin D, melasma contributes to sun exposed area of face.To correlate melasma with clinical evidence of periodontitis and vitamin D serum analysis along side hb %. Patients with facial melasma between 30-70yrs of either gender formed Group A (95). Anaemia and periodontitis were Clinically checked. Additionally serum analysis of vitamin D and hb percentage were analysed. Similar procedure was carried out on controls which had Group B (95) patients with no melasma on face. The study revealed significant correlation between melasma and periodontitis with vitamin D abnormalities (p value<.05), where as insignificant correlation between melasma and Hb%. The correlation between melasma, vitamin d changes and periodontitis may prompt the clinician to check for any such changes in any patient. Melasma in patients with periodontitis and serum vitamin D changes might be a considered as a syndrome.

NCT ID: NCT03238911 Completed - Clinical trials for Iron Deficiency Anemia

Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia

Start date: October 24, 2017
Phase: Phase 3
Study type: Interventional

The trial was designed to evaluate the incidence of unintended hypophosphatemia (low level of phosphate in the blood) in subjects with iron deficiency anaemia (IDA).

NCT ID: NCT03237065 Completed - Clinical trials for Iron Deficiency Anemia

Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia

Start date: October 30, 2017
Phase: Phase 3
Study type: Interventional

The trial was designed to evaluate the incidence of unintended hypophosphatemia (low level of phosphate in the blood) in subjects with iron deficiency anaemia (IDA).

NCT ID: NCT03236246 Completed - Clinical trials for Chronic Kidney Diseases

KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)

COMPASS
Start date: August 15, 2017
Phase: Phase 4
Study type: Interventional

The objectives of this study are to assess the long-term efficacy and safety of different dose regimens of KRX-0502 in the treatment of iron deficiency anemia (IDA) in adult subjects with non-dialysis dependent chronic kidney disease (CKD).